Citation Impact
Citing Papers
Inadequate erythropoietin response to anemia: definition and clinical relevance
1994
Triple-Negative Breast Cancer
2010 Standout
Chimerism of the Transplanted Heart
2002 Standout
Shadow enhancers: Frequently asked questions about distributed cis‐regulatory information and enhancer redundancy
2011
RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML)
1999
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin
2005 Standout
A rapid combined immunocytochemical and fluorescence in situ hybridisation method for the identification of human fetal nucleated red blood cells
1996
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
2009 Standout
A predictive model for the clinical response to low dose ara‐C: a study of 102 patients with myelodysplastic syndromes or acute leukaemia
1992
Epigenetics in human disease and prospects for epigenetic therapy
2004 StandoutNature
Cytogenetic responses in high-risk myelodysplastic syndrome following low-dose treatment with the DNA methylation inhibitor 5-aza-2'-deoxycytidine
2001
X chromosomal abnormalities in basal-like human breast cancer
2006
The present and future role of photodynamic therapy in cancer treatment
2004 Standout
Antimicrobial therapy of unexplained fever in neutropenic patients
2003
Murine embryonic stem cells without pig-a gene activity are competent for hematopoiesis with the PNH phenotype but not for clonal expansion.
1997
Review of the Incidence and Prognosis of Pseudomonas aeruginosa Infections in Cancer Patients in the 1990s
2000
A microduplication of the long range SHH limb regulator (ZRS) is associated with triphalangeal thumb-polysyndactyly syndrome
2008
Monoclonal expansion of synoviocytes in rheumatoid arthritis
1998
Heterogeneity of lineage involvement by trisomy 8 in myelodysplastic syndrome
1995
Cefoperazone versus ceftazidime monotherapy of nosocomial pneumonia
1988
Vascular disorders of the liver # †
2008 Standout
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
2006 Standout
Clonal cytogenetic abnormalities in bone marrow specimens without clear morphologic evidence of dysplasia: a form fruste of myelodysplasia?
2003
Evolving concepts of rheumatoid arthritis
2003 StandoutNature
Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America
2006 Standout
The Molecular Basis of Leukemia
1994
1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever
1997
Photodynamic therapy in lung cancer. A review
1996
Combined effects of vancomycin and imipenem against methicillin-resistant Staphylococcus aureus (MRSA) in vitro and in vivo
1999
Combined immunophenotyping and FISH with sex chromosome-specific DNA probes for the detection of chimerism in epidermal Langerhans cells after sex-mismatched bone marrow transplantation
1996
Identification of the active component that induces vancomycin resistance in MRSA
2010 StandoutNobel
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
2011 Standout
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
2011 Standout
IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans
2000 Standout
Transcription factors: from enhancer binding to developmental control
2012 Standout
Chapter 13 Long‐Range Gene Control and Genetic Disease
2008
Myelodysplastic syndrome and aplastic anemia: Distinct entities or diseases linked by a common pathophysiology?
2000
Acute Myelogenous Leukemia WithPIG-A Gene Mutation Evolved from Aplastic Anemia—Paroxysmal Nocturnal Hemoglobinuria Syndrome
2001
Multi-Organ, Multi-Lineage Engraftment by a Single Bone Marrow-Derived Stem Cell
2001 Standout
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell
1997 Standout
Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia
2003
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
2007 StandoutNature
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
Spatial partitioning of the regulatory landscape of the X-inactivation centre
2012 StandoutNature
Thrombosis of the Cerebral Veins and Sinuses
2005 Standout
Anemia of Chronic Disease
2005 Standout
Fibroblast‐like synoviocytes: key effector cells in rheumatoid arthritis
2009 Standout
Ventilator-associated Pneumonia
2002 Standout
Cytogenetic clonality in myelodysplastic syndromes studied with fluorescence in situ hybridization: lineage, response to growth factor therapy, and clone expansion
1993
Acquired somatic ATRX mutations in myelodysplastic syndrome associated with α thalassemia (ATMDS) convey a more severe hematologic phenotype than germline ATRX mutations
2003
Cefoperazone versus ceftriaxone monotherapy of nosocomial pneumonia
1992
Cytogenetically aberrant cells in the stem cell compartment (CD34+lin-) in acute myeloid leukemia.
1995
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Pten is essential for embryonic development and tumour suppression
1998 Standout
Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia
2013
Kit ligand improves in vitro erythropoiesis in myelodysplastic syndrome
1992
2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
2002 Standout
Analysis of meningiomas by methylation- and transcription-based clonality assays.
1995
In situ hybridization on May-Grunwald Giemsa-stained bone marrow and blood smears of patients with hematologic disorders allows detection of cell-lineage-specific cytogenetic abnormalities
1993
Evidence for nonclonal hematopoietic progenitor cell populations in bone marrow of patients with myelodysplastic syndromes
1994 StandoutNobel
Benzene increases aneuploidy in the lymphocytes of exposed workers: A comparison of data obtained by fluorescence in situ hybridization in interphase and metaphase cells
1999
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
2015 Standout
High rate of CAD gene amplification in human cells deficient in MLH1 or MSH6
2001 StandoutNobel
N-ras mutations are associated with poor prognosis and increased risk of leukemia in myelodysplastic syndrome
1993
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
The 5q-syndrome
1994
Natural History of Paroxysmal Nocturnal Hemoglobinuria
1995
Telomerase Activity in Human Gliomas
1998 StandoutNobel
Works of H van Kamp being referenced
Myelodysplasia following paroxysmal nocturnal haemoglobinuria: evidence for the emergence of a separate clone
1994
Effect of subcutaneously administered human recombinant erythropoietin on erythropoiesis in patients with myelodysplasia
1991
Comparison of Imipenem versus Cefuroxim Plus Tobramycin as Empirical Therapy for Febrile Granulocytopenic Patients and Efficacy of Vancomycin and Aztreonam in case of Failure
1994
Long-range conserved non-coding SHOX sequences regulate expression in developing chicken limb and are associated with short stature phenotypes in human patients
2006
Photodynamic Therapy as an Alternative Treatment for Surgery in a Patient with Lung Cancer Undergoing Bone Marrow Transplantation
1993
Combined immunophenotyping and DNA in situ hybridization to study lineage involvement in patients with myelodysplastic syndromes
1992
Studies on clonality by PCR analysis of the PGK-1 gene
1991
Myeloid but not lymphoid cells carry the 5q deletion: polymerase chain reaction analysis of loss of heterozygosity using mini-repeat sequences on highly purified cell fractions
1993
Detection of monosomy 7 and trisomy 8 in myeloid neoplasia: a comparison of banding and fluorescence in situ hybridization
1993
Myeloid but not lymphoid cells carry the 5q deletion: polymerase chain reaction analysis of loss of heterozygosity using mini-repeat sequences on highly purified cell fractions
1993
Longitudinal analysis of point mutations of the N-ras proto-oncogene in patients with myelodysplasia using archived blood smears
1992
Clonal involvement of granulocytes and monocytes, but not of T and B lymphocytes and natural killer cells in patients with myelodysplasia: analysis by X-linked restriction fragment length polymorphisms and polymerase chain reaction of the phosphoglycerate kinase gene
1992
Ceftazidime in serious hospital-acquired infections
1985
Clonal hematopoiesis in patients with acquired aplastic anemia [see comments]
1991